Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B3cfd63479230ddfa6da390ab1351f6d8> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B3cfd63479230ddfa6da390ab1351f6d8 NCIT_P378 "NCI" @default.
- B3cfd63479230ddfa6da390ab1351f6d8 type Axiom @default.
- B3cfd63479230ddfa6da390ab1351f6d8 annotatedProperty IAO_0000115 @default.
- B3cfd63479230ddfa6da390ab1351f6d8 annotatedSource NCIT_C106428 @default.
- B3cfd63479230ddfa6da390ab1351f6d8 annotatedTarget "The hydrochloride salt form of catequentinib, a receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic and anti-angiogenic activities. Upon administration, catequentinib targets multiple RTKs, including vascular endothelial growth factor receptor type 2 (VEGFR2) and type 3 (VEGFR3). This agent may both inhibit angiogenesis and halt tumor cell growth." @default.